tiprankstipranks
Trending News
More News >
Resmed (RMD)
NYSE:RMD
US Market
Advertisement

Resmed (RMD) Technical Analysis

Compare
1,130 Followers

Technical Sentiment

Overall Consensus
Neutral
9Bullish
5Neutral
8Bearish
Technical Analysis Consensus
Neutral
3Bullish
5Neutral
2Bearish
Moving Average Consensus
Neutral
6Bullish
0Neutral
6Bearish
Resmed’s (RMD) Moving Averages Convergence Divergence (MACD) indicator is -1.26, suggesting Resmed is a Buy.
Resmed’s (RMD) 20-Day exponential moving average is 273.43, while Resmed’s (RMD) share price is $268.22, making it a Sell.
Resmed’s (RMD) 50-Day exponential moving average is 273.18, while Resmed’s (RMD) share price is $268.22, making it a Sell.

Resmed (RMD) Pivot Points

Oct 22, 2025, 06:58 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
256.51
259.81
263.95
267.24
271.38
274.68
278.82
Fibonacci
259.81
262.65
264.40
267.24
270.08
271.84
274.68
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Resmed (RMD) Moving Averages

Oct 22, 2025, 06:58 AM
Period
Simple
Exponential
MA5
269.85Buy
270.77Buy
MA10
273.78Sell
272.17Sell
MA20
273.87Sell
273.43Sell
MA50
276.97Sell
273.18Sell
MA100
268.31Buy
267.17Buy
MA200
249.94Buy
254.48Buy
Resmed’s (RMD) 10-Day exponential moving average is 272.17, while Resmed’s (RMD) share price is $268.22, making it a Sell.
Resmed’s (RMD) 100-Day exponential moving average is 267.17, while Resmed’s (RMD) share price is $268.22, making it a Buy.
Resmed’s (RMD) stock price is $268.22 and Resmed’s (RMD) 50-day simple moving average is 276.97, creating a Sell signal.
Resmed’s (RMD) stock price is $268.22 and Resmed’s (RMD) 100-day simple moving average is 268.31, creating a Buy signal.
Resmed’s (RMD) stock price is $268.22 and Resmed’s (RMD) 200-day simple moving average is 249.94, creating a Buy signal.

Resmed (RMD) Technical Indicators

Oct 22, 2025, 06:58 AM
Name
Value
Implied Action
RSI (14)
46.27
Neutral
STOCH (9,6)
25.96
Neutral
STOCHRSI (14)
25.96
Neutral
MACD (12,26)
-1.26
Buy
ADX (14)
18.77
Buy
Williams %R
-61.83
Buy
CCI (14)
-67.00
Neutral
ATR (14)
5.56
-
Ultimate Oscillator
46.43
Neutral
ROC
-0.85
Sell
Resmed’s (RMD) Relative Strength Index (RSI) is 46.27, creating a Neutral signal.
Resmed’s (RMD) Trend Strength Indicator (ADX) is 18.77, creating a Buy signal.
Resmed’s (RMD) Commodity Channel Index (CCI) is -67.00, creating a Neutral signal.
Resmed’s (RMD) Price Rate of Change (ROC) is -0.85, creating a Sell signal.

FAQ

Is RMD a Buy, Hold, or Sell?
Based on RMD’s technical indicators, RMD is a Hold.
    What is RMD’s RSI (14)?
    RMD’s RSI (14) is 46.27, which suggests RMD is a Neutral.
      What is RMD’s MACD?
      RMD’s MACD is -1.26, which suggests RMD is a Buy.
        What is RMD’s 5-day moving average?
        RMD’s 5-day moving average is 269.85, which suggests RMD is a Buy.
          What is RMD’s 20-day moving average?
          RMD 20-day moving average is 273.87, which suggests RMD is a Sell.
            What is RMD’s 50-day moving average?
            RMD’s 50-day moving average is 276.97, which suggests RMD is a Sell.
              What is RMD’s 200-day moving average?
              RMD’s 200-day moving average is 249.94, which suggests RMD is a Buy.
                What is RMD’s Williams % R (14)?
                RMD’s Williams % R (14) is -61.83, which suggests RMD is a Buy.
                  What is RMD’s CCI (14)?
                  RMD’s CCI (14) is -67.00, which suggests RMD is a Neutral.
                    What am I Missing?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis